Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement.
Deighton, C
Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement. [electronic resource] - Rheumatology (Oxford, England) Nov 2008 - 1600-2 p. digital
Publication Type: Comparative Study; Editorial; Comment
1462-0332
10.1093/rheumatology/ken353 doi
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--drug therapy
France
Guideline Adherence
Healthcare Disparities
Humans
Patient Selection
Tumor Necrosis Factor-alpha--antagonists & inhibitors
United Kingdom
Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement. [electronic resource] - Rheumatology (Oxford, England) Nov 2008 - 1600-2 p. digital
Publication Type: Comparative Study; Editorial; Comment
1462-0332
10.1093/rheumatology/ken353 doi
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--drug therapy
France
Guideline Adherence
Healthcare Disparities
Humans
Patient Selection
Tumor Necrosis Factor-alpha--antagonists & inhibitors
United Kingdom